Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Tuesday 14 June, 2016

AstraZeneca PLC

Director/PDMR Shareholding

RNS Number : 1638B
AstraZeneca PLC
14 June 2016

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4


On 13 June 2016, the interest of Pascal Soriot, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.


The change in interest relates to the vesting of an award of shares made in June 2013 under the AstraZeneca Performance Share Plan.


Following the application of performance measures specified at the time of grant, Mr Soriot has become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed.


After sufficient vested shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Soriot has become beneficially entitled to and has received 84,316 shares into a personal brokerage account.


For tax purposes, the fair market value of the shares at vest was 3852 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.



A C N Kemp

Company Secretary

14 June 2016

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t